Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015841
Chunk: 14

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 14
---
 to our shareholders in the future may be different than what you might receive from other public reporting companies in which you hold equity interests.

Implications of Being a Smaller Reporting Company

Additionally, we are a "smaller reporting company," meaning that the market value of our common shares held by non-affiliates plus the proposed aggregate amount of gross proceeds to us as a result of this transaction is less than $700 million and our annual revenue is less than $100 million during the most recently completed fiscal year. As such, we are eligible for exemptions from various reporting requirements applicable to other public companies that are not smaller reporting companies, including, but not limited to, reduced disclosure obligations regarding executive compensation. We may continue to be a smaller reporting company as long as either (i) the market value of our common shares held by non-affiliates is less than $250 million or (ii) our annual revenue is less than $100 million during the most recently completed fiscal year and the market value of our common shares held by non-affiliates is less than $700 million.

<div align='center'>6

THE OFFERING</div>

This summary highlights information presented in greater detail elsewhere in this prospectus. This summary is not complete and does not contain all the information you should consider before investing in our securities. You should carefully read this entire prospectus before investing in our securities, including "Risk Factors" and our consolidated financial statements.

| Issuer                                        | Medicus Pharma Ltd.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Securities offered by the Selling Shareholder | 1,397,184 common shares                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Terms of the offering                         | Each Selling Shareholder will determine when and how it will dispose of any common shares registered under this prospectus for sale.                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Common shares to be outstanding               | 21,865,288 common shares                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Use of Proceeds                               | We will not receive any proceeds from the sale of the common shares offered by this prospectus by the Selling Shareholders.                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Voting rights                                 | Each outstanding common share will be entitled to one vote on all matters submitted to a vote of shareholders.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Listing                                       | Our common shares are listed on the Nasdaq under the symbol "MDCX".                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dividend policy                               | We do not anticipate that we will declare or pay dividends in the foreseeable future on our common shares. Instead, we anticipate that all of